Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Opinion
  • Published:

Surgery for asymptomatic degenerative aortic and mitral valve disease

Abstract

Degenerative valvular heart disease, the most common form of valve disease in the Western world, can lead to aortic stenosis (AS) or mitral regurgitation (MR). In current guidelines for the management of patients with degenerative valvular disease, surgical intervention is recommended at the onset of symptoms or in the presence of left ventricular systolic impairment. Whether surgery is appropriate for asymptomatic patients remains a controversial issue. We argue the case for early pre-emptive intervention in selected, asymptomatic individuals with AS or MR, drawing on contemporary perioperative data, predictors of disease progression, and studies of the natural history of degenerative valvular heart disease.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Kaplan–Meier event-free survival rate among patients with very severe aortic stenosis.
Figure 2: Survival free of cardiac-related death among 197 consecutive asymptomatic patients receiving conventional treatment for asymptomatic very severe aortic stenosis.
Figure 3: Postoperative survival data for patients undergoing mitral vale repair.
Figure 4: Surgical management of valvular heart disease.

Similar content being viewed by others

References

  1. Maganti, K., Rigolin, V. H., Sarano, M. E. & Bonow, R. O. Valvular heart disease: diagnosis and management. Mayo Clin. Proc. 85, 483–500 (2010).

    Article  PubMed  PubMed Central  Google Scholar 

  2. Goldbarg, S. H., Elmariah, S., Miller, M. A. & Fuster, V. Insights into degenerative aortic valve disease. J. Am. Coll. Cardiol. 50, 1205–1213 (2007).

    Article  PubMed  Google Scholar 

  3. Iung, B. et al. A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on Valvular Heart Disease. Eur. Heart J. 24, 1231–1243 (2003).

    Article  PubMed  Google Scholar 

  4. Bonow, R. O. et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 114, e84–e231 (2006).

    Article  PubMed  Google Scholar 

  5. Vahanian, A. et al. Guidelines on the management of valvular heart disease: the Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur. Heart J. 28, 230–268 (2007).

    PubMed  Google Scholar 

  6. Rosenhek, R. et al. Predictors of outcome in severe, asymptomatic aortic stenosis. N. Engl. J. Med. 343, 611–617 (2000).

    Article  CAS  PubMed  Google Scholar 

  7. Pellikka, P. A. et al. Outcome of 622 adults with asymptomatic, hemodynamically significant aortic stenosis during prolonged follow-up. Circulation 111, 3290–3295 (2005).

    Article  PubMed  Google Scholar 

  8. Rosenhek, R. et al. Natural history of very severe aortic stenosis. Circulation 121, 151–156 (2010).

    Article  PubMed  Google Scholar 

  9. Malaisrie, S. C. et al. Contemporary perioperative results of isolated aortic valve replacement for aortic stenosis. Ann. Thorac. Surg. 89, 751–756 (2010).

    Article  PubMed  Google Scholar 

  10. Kang, D. H. et al. Early surgery versus conventional treatment in asymptomatic very severe aortic stenosis. Circulation 121, 1502–1509 (2010).

    Article  PubMed  Google Scholar 

  11. Tribouilloy, C. M. et al. Impact of preoperative symptoms on survival after surgical correction of organic mitral regurgitation: rationale for optimizing surgical indications. Circulation 99, 400–405 (1999).

    Article  CAS  PubMed  Google Scholar 

  12. David, T. E., Ivanov, J., Armstrong, S. & Rakowski, H. Late outcomes of mitral valve repair for floppy valves: implications for asymptomatic patients. J. Thorac. Cardiovasc. Surg. 125, 1143–1152 (2003).

    Article  PubMed  Google Scholar 

  13. Enriquez-Sarano, M. & Sundt, T. M. 3rd. Early surgery is recommended for mitral regurgitation. Circulation 121, 804–811 (2010).

    Article  PubMed  Google Scholar 

  14. Goodney, P. P., O'Connor, G. T., Wennberg, D. E. & Birkmeyer, J. D. Do hospitals with low mortality rates in coronary artery bypass also perform well in valve replacement? Ann. Thorac. Surg. 76, 1131–1136 (2003).

    Article  PubMed  Google Scholar 

  15. Grigioni, F. et al. Atrial fibrillation complicating the course of degenerative mitral regurgitation: determinants and long-term outcome. J. Am. Coll. Cardiol. 40, 84–92 (2002).

    Article  PubMed  Google Scholar 

  16. Picano, E., Pibarot, P., Lancellotti, P., Monin, J. L. & Bonow, R. O. The emerging role of exercise testing and stress echocardiography in valvular heart disease. J. Am. Coll. Cardiol. 54, 2251–2260 (2009).

    Article  PubMed  Google Scholar 

  17. Das, P., Rimington, H. & Chamber, J. Exercise testing to stratify risk in aortic stenosis. Eur. Heart J. 26, 1309–1313 (2005).

    Article  PubMed  Google Scholar 

  18. Bergler-Klein, J. et al. Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis. Circulation 109, 2302–2308 (2004).

    Article  CAS  PubMed  Google Scholar 

  19. Pizarro, R. et al. Prospective validation of the prognostic usefulness of brain natriuretic peptide in asymptomatic patients with chronic severe mitral regurgitation. J. Am. Coll. Cardiol. 54, 1099–1106 (2009).

    Article  CAS  PubMed  Google Scholar 

  20. Messika-Zeitoun, D. et al. Cardiopulmonary exercise testing determination of functional capacity in mitral regurgitation: physiologic and outcome implications. J. Am. Coll. Cardiol. 47, 2521–2527 (2006).

    Article  PubMed  Google Scholar 

  21. Edwards, F. H. et al. Prediction of operative mortality after valve replacement surgery. J. Am. Coll. Cardiol. 37, 885–892 (2001).

    Article  CAS  PubMed  Google Scholar 

  22. Ambler, G. et al. Generic, simple risk stratification model for heart valve surgery. Circulation 112, 224–231 (2005).

    Article  PubMed  Google Scholar 

  23. Enriquez-Sarano, M. et al. Quantitative determinants of the outcome of asymptomatic mitral regurgitation. N. Engl. J. Med. 352, 875–883 (2005).

    Article  CAS  PubMed  Google Scholar 

  24. Rosenhek, R. et al. Outcome of watchful waiting in asymptomatic severe mitral regurgitation. Circulation 113, 2238–2244 (2006).

    Article  PubMed  Google Scholar 

  25. Enriquez-Sarano, M. et al. Echocardiographic prediction of survival after surgical correction of organic mitral regurgitation. Circulation 90, 830–837 (1994).

    Article  CAS  PubMed  Google Scholar 

  26. Shuhaiber, J. & Anderson, R. J. Meta-analysis of clinical outcomes following surgical mitral valve repair or replacement. Eur. J. Cardiothorac. Surg. 31, 267–275 (2003).

    Article  Google Scholar 

  27. Enriquez-Sarano, M. et al. Valve repair improves the outcome of surgery for mitral regurgitation. A multivariate analysis. Circulation 91, 1022–1028 (1995).

    Article  CAS  PubMed  Google Scholar 

  28. Adams, D. H. et al. Large annuloplasty rings facilitate mitral valve repair in Barlow's disease. Ann. Thorac. Surg. 82, 2096–2100 (2006).

    Article  PubMed  Google Scholar 

  29. Kang, D. H. et al. Comparison of early surgery versus conventional treatment in asymptomatic severe mitral regurgitation. Circulation 119, 797–804 (2009).

    Article  PubMed  Google Scholar 

  30. Gammie, J. S., O'Brien, S. M., Griffith, B. P., Ferguson, T. M. & Peterson, E. D. Influence of hospital procedural volume on care process and mortality for patients undergoing elective surgery for mitral regurgitation. Circulation 115, 881–887 (2007).

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

P. Vaishnava researched the data for the article, contributed substantially to the discussion of content, wrote the article, and reviewed and edited the manuscript before submission and after peer-review. V. Fuster, M. Goldman, and R. O. Bonow provided substantial contributions to the discussion of the content and to review and editing of the manuscript before submission and after peer-review.

Corresponding author

Correspondence to Prashant Vaishnava.

Ethics declarations

Competing interests

R. O. Bonow is a consultant on transcatheter valve technologies for Edwards LifeSciences. The other authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vaishnava, P., Fuster, V., Goldman, M. et al. Surgery for asymptomatic degenerative aortic and mitral valve disease. Nat Rev Cardiol 8, 173–177 (2011). https://doi.org/10.1038/nrcardio.2010.203

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrcardio.2010.203

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing